Haw Par Corp Ltd

H02

Company Profile

  • Business description

    Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.

  • Contact

    401 Commonwealth Drive
    No. 03-03 Haw Par Technocentre
    Singapore149598
    SGP

    T: +65 63379102

    https://www.hawpar.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    595

Stocks News & Analysis

stocks

ASX iron ore player downgraded ahead of earnings

Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks

Global tensions drive profitability for ASX energy provider

Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,405.4059.700.64%
CAC 408,665.031.60-0.02%
DAX 4026,207.214.860.02%
Dow JONES (US)54,085.88907.471.71%
FTSE 10010,891.0011.620.11%
HKSE25,915.8262.900.24%
NASDAQ26,584.99671.102.59%
Nikkei 22566,300.442,342.913.66%
NZX 50 Index13,997.1893.720.67%
S&P 5007,736.52136.021.79%
S&P/ASX 2009,227.8051.300.56%
SSE Composite Index3,878.4356.151.47%

Market Movers